Bnp Paribas Arbitrage, Snc »

Passage Bio shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Passage Bio (PASG) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Passage Bio

Tip: Access up to 7 years of quarterly data

All positions including Passage Bio held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Passage Bio by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-09-30 $96 12 8.00

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Meta Platforms Equity (META)
Apple Equity (AAPL)
Tesla Equity (TSLA)
Amazon.com Equity (AMZN)
iShares Core S&P 500 ETF Fund (IVV)
Broadcom Equity (AVGO)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOGL)
SPDR S&P 500 ETF Trust Fund (SPY)
iShares Russell 2000 ETF Fund (IWM)
Alphabet Equity (GOOG)
Cisco Systems Equity (CSCO)
General Electric Equity (GE)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Passage Bio

Lynx1 Capital Management
Vestal Point Capital
Erste Asset Management GmbH
Vanguard Group
Renaissance Technologies
Tang Capital Management
OrbiMed Advisors
BlackRock
Geode Capital Management
Acadian Asset Management
Squarepoint Ops
Bridgeway Capital Management
Citadel Advisors
Fiduciary Trust Company
Tower Research Capital

View all funds holding Passage Bio